Cerium oxide nanoparticles modulating the Parkinson's disease conditions: From the alpha synuclein structural point of view and antioxidant properties of cerium oxide nanoparticles
Authors:
Open Access
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Dielectrical Properties of CeO2 Nanoparticles at Different TemperaturesPLOS ONE, 2015
- Nanotechnology-mediated nose to brain drug delivery for Parkinson's disease: a mini reviewJournal of Drug Targeting, 2015
- Synthesis, characterization and photoluminescence of CeO2 nanoparticles by a facile method at room temperatureJournal of Alloys and Compounds, 2010
- Synthesis, structural and optical properties of CeO2 nanoparticles synthesized by a simple polyvinyl pyrrolidone (PVP) solution routeMaterials Chemistry and Physics, 2009
- Treatment of Parkinson’s Disease with Trophic FactorsNeurotherapeutics, 2008
- Synthesis and acid functionalization of cerium oxide nanoparticlesJournal of Sol-Gel Science and Technology, 2006
- Synthesis of nanocrystalline cerium oxide particles by the precipitation methodCeramics International, 2005
- Combustion Synthesis and Characterization of Nanocrystalline CeO2-Based PowdersChemistry of Materials, 2004
- Techniques to study amyloid fibril formation in vitroMethods, 2004
- Effect of trihexyphenidyl, a non-selective antimuscarinic drug, on decarboxylation of l-dopa in hemi-Parkinson ratsEuropean Journal of Pharmacology, 1998